The anticipated off-patent status of GLP-1 drugs within the next decade will furthermore allow for cheaper generic versions, making these medications more affordable and accessible
This laid the groundwork for a collaboration with Heinrich and Wilson, who were working on the rat pancreatic preproglucagon in Habener's laboratory
Emerging evidence suggests that ferroptosis contributes to the pathogenesis of AP
Can you give us a brief explanation of how they work in general
We propose that GLP-1 analogs are superior to DPP-4 inhibitors for managing pasireotide-induced hyperglycemia because GLP-1 analogs, unlike DPP-4 inhibitors, spare pasireotide-induced depletion of endogenous GLP-1 and restore insulin secretion suppressed by pasireotide through GLP-1R-Gs activation, counteracting the SSTRs-Gi axis
These GLP-1based treatments support healthy, sustainable weight loss often making patients safer surgical candidates and enhancing their overall results